Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419643449> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2419643449 endingPage "81" @default.
- W2419643449 startingPage "577" @default.
- W2419643449 abstract "Sulfasalazine (SLZ) is now a second-line treatment in rheumatoid arthritis (RA), as well as in psoriatic arthritis and ankylosing spondylitis. 54 patients with active RA were treated with enteric coated SLZ (2 g daily) in a 24-week open study. Clinical and laboratory parameters of disease activity were monitored initially and thereafter at 2-week intervals for the first 2 months, and then at 4-week intervals until the end of the 24-week study. There was significant clinical improvement at the end, as shown by scores for joint pain (Ritchie), grip strength and morning stiffness (p less than 0.0001, less than 0.0001 and less than 0.01, respectively, by paired t test). Clinical improvement was accompanied by significant decrease in erythrocyte sedimentation rate and increase in hemoglobin (p less than 0.002 and less than 0.016, respectively). There was improvement in some cases as early as 3 weeks after starting therapy. The drop-out rate was significant: 19/54 (35%), most (13) due to side-effects, mainly gastrointestinal; none of the side-effects were serious. Our results, similar to those of other studies, indicate that despite the high rate of side effects, SLZ is an effective, second-line drug for RA." @default.
- W2419643449 created "2016-06-24" @default.
- W2419643449 creator A5007309500 @default.
- W2419643449 creator A5017410476 @default.
- W2419643449 creator A5025686273 @default.
- W2419643449 creator A5032723586 @default.
- W2419643449 creator A5047315370 @default.
- W2419643449 creator A5048094256 @default.
- W2419643449 creator A5064429330 @default.
- W2419643449 creator A5065925918 @default.
- W2419643449 creator A5069684162 @default.
- W2419643449 creator A5090429794 @default.
- W2419643449 date "1991-05-15" @default.
- W2419643449 modified "2023-09-27" @default.
- W2419643449 title "[Sulfasalazine in rheumatoid arthritis]." @default.
- W2419643449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1682225" @default.
- W2419643449 hasPublicationYear "1991" @default.
- W2419643449 type Work @default.
- W2419643449 sameAs 2419643449 @default.
- W2419643449 citedByCount "6" @default.
- W2419643449 crossrefType "journal-article" @default.
- W2419643449 hasAuthorship W2419643449A5007309500 @default.
- W2419643449 hasAuthorship W2419643449A5017410476 @default.
- W2419643449 hasAuthorship W2419643449A5025686273 @default.
- W2419643449 hasAuthorship W2419643449A5032723586 @default.
- W2419643449 hasAuthorship W2419643449A5047315370 @default.
- W2419643449 hasAuthorship W2419643449A5048094256 @default.
- W2419643449 hasAuthorship W2419643449A5064429330 @default.
- W2419643449 hasAuthorship W2419643449A5065925918 @default.
- W2419643449 hasAuthorship W2419643449A5069684162 @default.
- W2419643449 hasAuthorship W2419643449A5090429794 @default.
- W2419643449 hasConcept C126322002 @default.
- W2419643449 hasConcept C141071460 @default.
- W2419643449 hasConcept C199360897 @default.
- W2419643449 hasConcept C2776237595 @default.
- W2419643449 hasConcept C2776260265 @default.
- W2419643449 hasConcept C2777402515 @default.
- W2419643449 hasConcept C2777433710 @default.
- W2419643449 hasConcept C2777575956 @default.
- W2419643449 hasConcept C2778143017 @default.
- W2419643449 hasConcept C2779134260 @default.
- W2419643449 hasConcept C2779383735 @default.
- W2419643449 hasConcept C2780479503 @default.
- W2419643449 hasConcept C2909196033 @default.
- W2419643449 hasConcept C3454156 @default.
- W2419643449 hasConcept C41008148 @default.
- W2419643449 hasConcept C71924100 @default.
- W2419643449 hasConcept C90924648 @default.
- W2419643449 hasConceptScore W2419643449C126322002 @default.
- W2419643449 hasConceptScore W2419643449C141071460 @default.
- W2419643449 hasConceptScore W2419643449C199360897 @default.
- W2419643449 hasConceptScore W2419643449C2776237595 @default.
- W2419643449 hasConceptScore W2419643449C2776260265 @default.
- W2419643449 hasConceptScore W2419643449C2777402515 @default.
- W2419643449 hasConceptScore W2419643449C2777433710 @default.
- W2419643449 hasConceptScore W2419643449C2777575956 @default.
- W2419643449 hasConceptScore W2419643449C2778143017 @default.
- W2419643449 hasConceptScore W2419643449C2779134260 @default.
- W2419643449 hasConceptScore W2419643449C2779383735 @default.
- W2419643449 hasConceptScore W2419643449C2780479503 @default.
- W2419643449 hasConceptScore W2419643449C2909196033 @default.
- W2419643449 hasConceptScore W2419643449C3454156 @default.
- W2419643449 hasConceptScore W2419643449C41008148 @default.
- W2419643449 hasConceptScore W2419643449C71924100 @default.
- W2419643449 hasConceptScore W2419643449C90924648 @default.
- W2419643449 hasIssue "10" @default.
- W2419643449 hasLocation W24196434491 @default.
- W2419643449 hasOpenAccess W2419643449 @default.
- W2419643449 hasPrimaryLocation W24196434491 @default.
- W2419643449 hasRelatedWork W2024691000 @default.
- W2419643449 hasRelatedWork W2196308175 @default.
- W2419643449 hasRelatedWork W2352482932 @default.
- W2419643449 hasRelatedWork W2369656470 @default.
- W2419643449 hasRelatedWork W2370861219 @default.
- W2419643449 hasRelatedWork W2388286102 @default.
- W2419643449 hasRelatedWork W2419643449 @default.
- W2419643449 hasRelatedWork W2436497122 @default.
- W2419643449 hasRelatedWork W3030667650 @default.
- W2419643449 hasRelatedWork W2474181391 @default.
- W2419643449 hasVolume "120" @default.
- W2419643449 isParatext "false" @default.
- W2419643449 isRetracted "false" @default.
- W2419643449 magId "2419643449" @default.
- W2419643449 workType "article" @default.